Pfizer reports fatality in Phase II DMD gene therapy study
The company paused participant dosing associated with the crossover portion of its Phase III CIFFREO trial.
08 May 2024
08 May 2024
The company paused participant dosing associated with the crossover portion of its Phase III CIFFREO trial.
The transformative potential of decentralised clinical trials (DCTs) has been heralded in recent years.
The Outsourcing in Clinical Trials Europe conference heard how study costs could be reduced by using data from EHRs.
Although it is important to consider the patient when planning trials, ensuring that all parties have a say is a better solution.
According to the initial data, NGN-401 was found to be well-tolerated by all three patients dosed.
The trial will assess the safety and efficacy of PEP when applied topically to DFUs.
Enstilar demonstrated superiority in both primary and secondary endpoints of the trial.
The primary endpoint of the trial is pain relief.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.